Precision medicine in human heart modeling Perspectives, challenges, and opportunities

被引:108
作者
Peirlinck, M. [1 ]
Costabal, F. Sahli [2 ]
Yao, J. [3 ]
Guccione, J. M. [4 ]
Tripathy, S. [5 ]
Wang, Y. [6 ]
Ozturk, D. [7 ]
Segars, P. [8 ]
Morrison, T. M. [9 ]
Levine, S. [3 ]
Kuhl, E. [1 ,10 ]
机构
[1] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA
[2] Pontificia Univ Catholica Chile, Dept Mech Engn, Santiago, Chile
[3] Dassault Syst Simulia Corp, Johnston, RI USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Edwards Lifesci, Irvine, CA USA
[6] Thornton Tomasetti Inc, Santa Clara, CA USA
[7] Capvidia, Leuven, Belgium
[8] Duke Univ, Dept Radiol, Carl E Ravin Adv Imaging Labs, Durham, NC 27710 USA
[9] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA
[10] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
关键词
Precision medicine; Electrophysiology; Cardiac mechanics; Fluid dynamics; Finite element simulation; Machine learning; Digital twin;
D O I
10.1007/s10237-021-01421-z
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Precision medicine is a new frontier in healthcare that uses scientific methods to customize medical treatment to the individual genes, anatomy, physiology, and lifestyle of each person. In cardiovascular health, precision medicine has emerged as a promising paradigm to enable cost-effective solutions that improve quality of life and reduce mortality rates. However, the exact role in precision medicine for human heart modeling has not yet been fully explored. Here, we discuss the challenges and opportunities for personalized human heart simulations, from diagnosis to device design, treatment planning, and prognosis. With a view toward personalization, we map out the history of anatomic, physical, and constitutive human heart models throughout the past three decades. We illustrate recent human heart modeling in electrophysiology, cardiac mechanics, and fluid dynamics and highlight clinically relevant applications of these models for drug development, pacing lead failure, heart failure, ventricular assist devices, edge-to-edge repair, and annuloplasty. With a view toward translational medicine, we provide a clinical perspective on virtual imaging trials and a regulatory perspective on medical device innovation. We show that precision medicine in human heart modeling does not necessarily require a fully personalized, high-resolution whole heart model with an entire personalized medical history. Instead, we advocate for creating personalized models out of population-based libraries with geometric, biological, physical, and clinical information by morphing between clinical data and medical histories from cohorts of patients using machine learning. We anticipate that this perspective will shape the path toward introducing human heart simulations into precision medicine with the ultimate goals to facilitate clinical decision making, guide treatment planning, and accelerate device design.
引用
收藏
页码:803 / 831
页数:29
相关论文
共 50 条
  • [41] OPPORTUNITIES FOR PRECISION MEDICINE AND PRECISION PUBLIC HEALTH IN SAUDI ARABIA
    Alshehri, Abdulrahim Abdullah
    Ambrosino, Elena
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 2118 - 2127
  • [42] Religious Perspectives on Precision Medicine in Singapore
    Hui Jin Toh
    Angela Ballantyne
    Serene Ai Kiang Ong
    Chitra Sankaran
    Hung Yong Tay
    Malminderjit Singh
    Raza Zaidi
    Roland Chia
    Sarabjeet Singh
    Swami Samachittananda
    You Guang Shi
    Zhixia Tan
    Tamra Lysaght
    Asian Bioethics Review, 2021, 13 : 473 - 483
  • [43] Religious Perspectives on Precision Medicine in Singapore
    Toh, Hui Jin
    Ballantyne, Angela
    Ong, Serene Ai Kiang
    Sankaran, Chitra
    Tay, Hung Yong
    Singh, Malminderjit
    Zaidi, Raza
    Chia, Roland
    Singh, Sarabjeet
    Samachittananda, Swami
    Shi, You Guang
    Tan, Zhixia
    Lysaght, Tamra
    ASIAN BIOETHICS REVIEW, 2021, 13 (04) : 473 - 483
  • [44] Risk Stratification Towards Precision Medicine in Heart Failure - Current Progress and Future Perspectives -
    Nagai, Toshiyuki
    Nakao, Motoki
    Anzai, Toshihisa
    CIRCULATION JOURNAL, 2021, 85 (05) : 576 - 583
  • [45] Challenges in IBD Research: Precision Medicine
    Denson, Lee A.
    Curran, Mark
    McGovern, Dermot P. B.
    Koltun, Walter A.
    Duerr, Richard H.
    Kim, Sandra C.
    Sartor, R. Balfour
    Sylvester, Francisco A.
    Abraham, Clara
    de Zoeten, Edwin F.
    Siegel, Corey A.
    Burns, Richeal M.
    Dobes, Angela M.
    Shtraizent, Nataly
    Honig, Gerard
    Heller, Caren A.
    Hurtado-Lorenzo, Andres
    Cho, Judy H.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S31 - S39
  • [46] Implications and opportunities of precision medicine in rare malignancies
    Conley, Barbara A.
    Sorg, Brian S.
    Tricoli, James V.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (09): : 953 - 960
  • [47] Machine Learning for Precision Psychiatry: Opportunities and Challenges
    Bzdok, Danilo
    Meyer-Lindenberg, Andreas
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2018, 3 (03) : 223 - 230
  • [48] Difficulties and challenges in the development of precision medicine
    Liu, Xiaoqin
    Luo, Xin
    Jiang, Chunyang
    Zhao, Hui
    CLINICAL GENETICS, 2019, 95 (05) : 569 - 574
  • [49] Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine
    Van den Bossche, Valentin
    Zaryouh, Hannah
    Vara-Messler, Marianela
    Vignau, Julie
    Machiels, Jean-Pascal
    Wouters, An
    Schmitz, Sandra
    Corbet, Cyril
    DRUG RESISTANCE UPDATES, 2022, 60
  • [50] Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview
    Shah, Sanjiv J.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2017, 10 (03) : 233 - 244